Ambee Pharmaceuticals Limited reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 56.92 million compared to BDT 63.28 million a year ago. Net income was BDT 0.841 million compared to BDT 0.566 million a year ago. Basic earnings per share from continuing operations was BDT 0.35 compared to BDT 0.24 a year ago.
For the six months, sales was BDT 105.86 million compared to BDT 107.09 million a year ago. Net income was BDT 1.46 million compared to BDT 0.814 million a year ago. Basic earnings per share from continuing operations was BDT 0.6 compared to BDT 0.34 a year ago.